ImaBiotech (Group)

https://www.imabiotech.com

ImaBiotech is a Contract Research Organization (CRO) with facilities in Boston (MA, USA) and Lille (Eurasanté Parc, France). The company offers innovative services and software to the pharmaceutical research sector, providing highly in vivo informative drug efficacy and toxicity evaluations during preclinical and clinical stage developments at cellular level, making better and safer drugs. Services are based on histology combined to label free molecular imaging (Quantitative Mass Spectrometry Imaging, QMSI) a technology developed and constantly improved by ImaBiotech. QMSI is a game changer for the pharmaceutical industry in all therapeutic areas. While other techniques provide global information, this molecular technique provides a deeper understanding of a drugs localization and its pharmacological effects at cellular level. This improves the interpretation of drug efficacy and toxicity, resulting in better drugs and decreasing time-to-market. *

Contact: contact@imabiotech.com

Profile: Located in Europe (France) and North America (Cambridge, MA), ImaBiotech develops and offers new imaging technologies, applications and software (Quantinetix™, Multimaging™). In order to accelerates drug development with innovative & proprietary imaging technologies, ImaBiotech offers Mass Spectrometry Imaging Services to provide a cost-effective solution to preclinical and clinical studies. This molecular technique is used for qualitative & quantitative efficacy and toxicity evaluations of drug candidates from the whole body to cell levels.

Industry: Biotechnology

Products/Services: Biomarker discovery, target engagement, analysis of quantitative distributions of your lead compounds, toxicity studies with QMSI to identify the relation between drug, metabolites and toxicity.

Established: 2009

Employees: 20

Partners: Bruker, Prof. Ron Heern, Dr. Walter Korfmacher, Dr. Markus Stoeckli

The organisation submitted the information to [MSC] on 21 March 2016.

	Start	2009-01-01 established
	Industry	mass spectrometry software (MS software)
	Industry 2	Quantinetix™ software for quantitative MALDI imaging
	Person	Stauber, Jonathan (ImaBiotech 201206 CEO)
	Person 2	Bonnel, David (ImaBiotech 201901 Executive Director)

	Region	Loos (Loos-lez-Lille)
	Country	France
	Street	885 Avenue Eugène Avinée
	City	59120 Loos
	Tel	+33-9-7044-0008
		Address record changed: 2020-12-02

Basic data	Employees	B: 11 to 50 (2016-03-21)

		* Document for »About Section«: ImaBiotech SAS. (1/17/19). "Press Release: OCR and ImaBiotech Initiate a Strategic Partnership to Provide in situ Drug Efficacy and Target Exposure Services in Pets with Naturally Occuring Tumors". Lille.

		Record changed: 2024-02-12

Top News

Upcoming Events

Management Appointments

Financings & Acquisitions

Collaborations & Licensing

At Investor Conferences

Associations

Advertise

ImaBiotech (Group)

More documents for ImaBiotech (Group)